Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Motives and Side-Effects of Microdosing With Psychedelics Among Users
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 7, pp. 426-434
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Friederike Holze, Patrick Vizeli, Laura Ley, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 537-544
Open Access | Times Cited: 178
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers, Livia Ng, David Erritzøe, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1039-1057
Open Access | Times Cited: 169
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 161
Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
Hannes Kettner, Fernando E. Rosas, Christopher Timmermann, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 143
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
Laura Kaertner, Michael B. Steinborn, Hannes Kettner, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 108
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Federico Cavanna, Stephanie Müller, Laura Alethia de la Fuente, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 77
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field
Vince Polito, Paul Liknaitzky
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104706-104706
Open Access | Times Cited: 69
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials
Juan José Fuentes, Francina Fonseca, Matilde Elices, et al.
Frontiers in Psychiatry (2020) Vol. 10
Open Access | Times Cited: 136
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
European Neuropsychopharmacology (2020) Vol. 41, pp. 81-91
Open Access | Times Cited: 94
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
International Journal of Drug Policy (2019) Vol. 75, pp. 102600-102600
Closed Access | Times Cited: 85
Psychedelic Microdosing: Prevalence and Subjective Effects
Lindsay P. Cameron, Angela Nazarian, David E. Olson
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 2, pp. 113-122
Open Access | Times Cited: 82
Investigation of the Structure–Activity Relationships of Psilocybin Analogues
Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, et al.
ACS Pharmacology & Translational Science (2020) Vol. 4, Iss. 2, pp. 533-542
Open Access | Times Cited: 78
The acute effects of classic psychedelics on memory in humans
C. J. Healy
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 639-653
Closed Access | Times Cited: 71
Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP
Ofir Livne, Dvora Shmulewitz, Claire Walsh, et al.
Addiction (2022) Vol. 117, Iss. 12, pp. 3099-3109
Open Access | Times Cited: 53
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1749-1763
Open Access | Times Cited: 38
Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review
Jan Lazur, Kamil Hnatyk, Katarzyna Kała, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 623-623
Open Access | Times Cited: 34
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J. Murphy, Rachael L. Sumner, William J. Evans, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 6, pp. 511-521
Open Access | Times Cited: 28
Trends in drug use among nightclub and festival attendees in New York City, 2017-2022
Joseph J. Palamar, Austin Le, Charles M. Cleland, et al.
International Journal of Drug Policy (2023) Vol. 115, pp. 104001-104001
Open Access | Times Cited: 24
Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins
Antonin Rouaud, Abigail E. Calder, Gregor Hasler
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 217-224
Open Access | Times Cited: 12
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine
Conor H. Murray, Joel Frohlich, Connor J. Haggarty, et al.
Neuropsychopharmacology (2024)
Closed Access | Times Cited: 11
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
Nadia R. P. W. Hutten, Natasha L. Mason, Patrick C. Dolder, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 59
The therapeutic potential of microdosing psychedelics in depression
Kim P. C. Kuypers
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 58
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 6, pp. 612-622
Closed Access | Times Cited: 54
Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders
Toby Lea, Nicole Amada, Henrik Jungaberle, et al.
Psychopharmacology (2020) Vol. 237, Iss. 5, pp. 1521-1532
Closed Access | Times Cited: 51
Psychedelics as a Treatment for Alzheimer’s Disease Dementia
Simon Vann Jones, Allison O’Kelly
Frontiers in Synaptic Neuroscience (2020) Vol. 12
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top